These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36313668)

  • 21. New drugs in gastrointestinal stromal tumors.
    Martin-Broto J; Moura DS
    Curr Opin Oncol; 2020 Jul; 32(4):314-320. PubMed ID: 32541319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenib.
    Mohammadi M; Gelderblom H
    Expert Opin Investig Drugs; 2021 Feb; 30(2):143-152. PubMed ID: 33252274
    [No Abstract]   [Full Text] [Related]  

  • 23. Avances en tumores del estroma gastrointestinal: ¿hacia dónde vamos?
    Fernández-Hernández JA; Cantín-Blázquez S; García-Somacarrera E; Varo-Pérez E; González-López JA; Asencio-Pascual JM; Mendiola M; Serrano C; García-Granero E; Artigas-Raventós V
    Cir Cir; 2022; 90(2):267-277. PubMed ID: 35350056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates.
    Farag S; Smith MJ; Fotiadis N; Constantinidou A; Jones RL
    Curr Treat Options Oncol; 2020 May; 21(7):55. PubMed ID: 32462367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advanced GIST: Which treatments in 2022?].
    Mas L; Bachet JB
    Bull Cancer; 2022 Oct; 109(10):1082-1087. PubMed ID: 35934543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of Type I and II tyrosine kinase inhibitors-avapritinib and sunitinib-in refractory gastrointestinal stromal tumor after failure to multi-line therapy: a case report.
    Guo X; Huang S; Shi Y; Guan Z; Chen S; Feng Y; Xia Y; Zhang X
    Ann Transl Med; 2022 Sep; 10(18):1026. PubMed ID: 36267752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal stromal tumor: a review of current and emerging therapies.
    Al-Share B; Alloghbi A; Al Hallak MN; Uddin H; Azmi A; Mohammad RM; Kim SH; Shields AF; Philip PA
    Cancer Metastasis Rev; 2021 Jun; 40(2):625-641. PubMed ID: 33876372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corrigendum: Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review.
    Rony M; Ratone JP; Walz J; Pignot G; Caillol F; Pesenti C; Guerin M; Dermeche S; Brunelle S; Salem N; Vicier C; Rybikowski S; Maubon T; Fakhfakh S; Tejeda M; Giovannini M; Gravis G
    Front Oncol; 2021; 11():710477. PubMed ID: 34195098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into the clinical management of advanced gastrointestinal stromal tumors.
    Italiano A
    Expert Opin Pharmacother; 2021 Mar; 22(4):439-447. PubMed ID: 33307872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic Therapy for Gastrointestinal Stromal Tumor: Current Standards and Emerging Challenges.
    Huang WK; Wu CE; Wang SY; Chang CF; Chou WC; Chen JS; Yeh CN
    Curr Treat Options Oncol; 2022 Sep; 23(9):1303-1319. PubMed ID: 35976553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal stromal tumors (GIST) related emergencies.
    Sorour MA; Kassem MI; Ghazal Ael-H; El-Riwini MT; Abu Nasr A
    Int J Surg; 2014; 12(4):269-80. PubMed ID: 24530605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Avapritinib in advanced gastrointestinal stromal tumor: case series and review of the literature from a tertiary care center in India.
    Verma S; Reddy R; Chandrashekhara SH; Shamim SA; Tripathy S; Rastogi S
    Future Sci OA; 2021 Jan; 7(4):FSO676. PubMed ID: 33815822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of an innovative nursing exchange programme: health counselling skills and cultural awareness.
    Lee RL; Pang SM; Wong TK; Chan MF
    Nurse Educ Today; 2007 Nov; 27(8):868-77. PubMed ID: 17254670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ripretinib turns off the switch in GIST.
    Villanueva MT
    Nat Rev Cancer; 2019 Jul; 19(7):370. PubMed ID: 31201392
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessing the evolution of scientific publications in orthopedics journals from mainland China, Hong Kong, and Taiwan: a 12-year survey of the literature.
    Jiang H; Nong B; Yang L; Zong S; Zhan X; Wei Q; Xiao Z
    J Orthop Surg Res; 2016 Jun; 11(1):69. PubMed ID: 27317092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erratum: The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique [Corrigendum].
    Drug Des Devel Ther; 2023; 17():3537-3538. PubMed ID: 38046283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ripretinib (Qinlock) for GIST.
    Med Lett Drugs Ther; 2021 Apr; 63(1621):e56-e57. PubMed ID: 33830971
    [No Abstract]   [Full Text] [Related]  

  • 38. An updated review of the treatment landscape for advanced gastrointestinal stromal tumors.
    Patel SR; Reichardt P
    Cancer; 2021 Jul; 127(13):2187-2195. PubMed ID: 33974733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scientific publications in nursing journals from Mainland China, Taiwan, and Hong Kong: a 10-year survey of the literature.
    Zhang D; Wang X; Yuan X; Yang L; Xue Y; Xie Q
    PeerJ; 2016; 4():e1798. PubMed ID: 26989631
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.